Log in to save to my catalogue

Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real wo...

Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real wo...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_43e03c8577e3401699a0eac8f43eb23f

Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma

About this item

Full title

Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma

Publisher

London: Nature Publishing Group UK

Journal title

Blood cancer journal (New York), 2024-11, Vol.14 (1), p.197-5, Article 197

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_43e03c8577e3401699a0eac8f43eb23f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_43e03c8577e3401699a0eac8f43eb23f

Other Identifiers

ISSN

2044-5385

E-ISSN

2044-5385

DOI

10.1038/s41408-024-01183-8

How to access this item